Spatially and temporally regulated activity of Branchless/Breathless signaling is essential for trachea development in Drosophila. Early ubiquitous breathless (btl) expression is controlled by binding of Trachealess/Tango heterodimers to the btl minimum enhancer. Branchless/ Breathless signaling includes a Sprouty-dependent negative feedback loop. We show that late btl expression is a target of Branchless/ Breathless signaling and hence, Branchless/Breathless signaling contains a positive feedback loop, which may guarantee a continuous supply of fresh receptors to membranes of growing tracheal branch cells. Branchless/Breathless signaling activates MAP-kinase, which in turn, activates late btl expression and destabilizes Anterior-open, a repressor for late btl expression. Biochemical and genetic analysis indicated that the minimum btl enhancer includes binding sites of Anterior-open. q
Introduction
Multicellular organisms require oxygen and have developed a unique tracheal system (respiratory system) for oxygen uptake. The trachea is a tubular structure that delivers oxygen to tissues. Though this system shows highly divergent morphology, some aspects of the molecular mechanism underlying trachea formation appear conserved in both vertebrates and invertebrates (Metzger and Krasnow, 1999) .
In Drosophila, tracheal development proceeds through many cellular processes including cell migration and cell fate determination (Manning and Krasnow, 1993; Samakovlis et al., 1996; Metzger and Krasnow, 1999) . Trachea formation is initiated at a midembryonic stage. The organ arises from 20 tracheal placodes that are clusters of ectodermal origin. Each tracheal placode, consisting of about 80 tracheal primordia, invaginates into the interior of the embryo to form a tracheal pit. Cells in each such pit subdivide into distinct domains through the concerted action of Decapentaplegic (Dpp; Vincent et al., 1997) , Wingless (Wg; Chihara and Hayashi, 2000; Llimargas, 2000) , Spitz/DER (Wappner et al., 1997) and Hedgehog (Hh; Glazer and Shilo, 2001 ) signaling pathways and then migrate to form six multicellular tubes or primary branches, each consisting of a fixed number of cells (see Fig. 1N ; Manning and Krasnow, 1993; Samakovlis et al., 1996) .
During late stages of tracheal development, other modes of branching occur. A subset of tracheal cells near the ends of primary branches begins to form unicellular secondary branches. Pointed (Pnt), an Ets-domain-containing transcription factor, is essential for the fate of secondarybranch-forming cells (Klambt, 1993; Samakovlis et al., 1996) . Certain secondary-branch-forming cells send out long cytoplasmic processes toward target tissues to form terminal branches . Initially equivalent secondary-branch forming cells subdivide into terminal and fusion cells and this cell fate choice is regulated by Notch/Delta signaling (Ikeya and Hayashi, 1999; Llimargas, 1999) .
breathless (btl) encodes a Drosophila FGF receptor and is indispensable to development of the trachea (Klambt et al., 1992) . This gene is required not only for cell migration during primary branching but for the expression of genes essential for secondary and/or terminal branch formation as well (Reichman-Fried and Shilo, 1995; Samakovlis et al., 1996) . branchless (bnl) encodes a Drosophila FGF that serves as ligand for Btl . Bnl is expressed in discrete sets of cells surrounding developing trachea and considered to serve as a motogen or chemoattractant for tracheal cell migration during primary branching . At later developmental stages, Bnl expressed in restricted areas bestows secondary-branchforming cell fates to cells in the vicinity of the ends of growing primary branches. Bnl/Btl signaling is also essential for terminal cell fate (Reichman-Fried and Shilo, 1995; Guillemin et al., 1996; Sutherland et al., 1996 , Hacohen et al., 1998 . Thus, the development of Drosophila trachea is under the control of spatially and temporally regulated activity of Bnl/Btl signaling throughout development Sutherland et al., 1996) .
In a previous experiment (Ohshiro and Saigo, 1997) , we identified the minimum enhancer region of btl, cloned dArnt (tango (tgo)) and showed biochemical and genetic evidence that btl expression in early tracheal cells is regulated by direct interactions between Trachealess (Trh)/Tgo heterodimers and three central midline elements (CMEs) situated in this enhancer region. btl RNA expression in tracheal cells was also noted to dynamically change and be restricted to secondary-branch-forming cells at later stages. Sprouty (Spry), an intracellular inhibitor of the Ras/ MAPK pathway, is involved in Bnl/Btl signaling (Hacohen et al., 1998; Casci et al., 1999) . Spry prevents growing branch cells other than presumptive tip cells from taking on secondary-branch-forming cell fate.
Here we show that late btl expression is a target of Bnl/Btl signaling. That is, Bnl/Btl signaling includes a positive feed- . Prominent btl expression can be seen in LTa/p, which is overlaid by lateral bnl clusters (arrowheads). (D) An optical section including btl (green)-expressing VB (arrows) immediately adjacent to the visceral mesoderm (arrowheads) expressing bnl (red). (E) Dorsal-lateral view focused on DB cells expressing btl (green) and ectodermal cells expressing bnl (red). btl is most strongly expressed at tips of DBs immediately adjacent to the dorsal bnl clusters (see arrows). Note that btl expression in DT is very weak, irrespective of the fact that bnl is expressed in cells overlaying DT tips (arrowheads). Btl protein distribution (F) is similar to the btl RNA expression pattern, btl expression is virtually lost in bnl mutant embryos (G), suggesting that bnl is required for late btl expression. (H) btl expression in a UAS-bnl/ptc-Ga14 embryo. Note that btl expression is extensively enhanced. Similarly enhanced btl expression could be seen when another ectodermal Ga14 driver, 69B-Gal4 was used (data not shown). In contrast, btl-lacZ expression was not enhanced in embryos homozygous for btlD Oh 10, an enhancer-trap-derived btl null allele associated with intact lacZ under the control of normal btl enhancer, even in the presence of UAS-bnl/ptc-Gal4 (I), indicating that Btl activity is required for its induction by Bnl. (J) btl-lacZ expression in tracheal cells (black arrows) was considerably enhanced in btl D Oh10 /TM6B Abd-lacZ transheterozygous embryos in the presence of UAS-bnl/ptc-Gal4. Note that lacZ signals in the embryo possessing one copy of intact btl gene and a copy of lacZ gene governed by the btl enhancer (J) is much stronger than those in the embryo with two copies of lacZ genes driven by the normal btl enhancer but lacking intact btl genes (I), indicating the importance of the presence of intact btl in efficient btl-lacZ expression. The white bracket indicates the mesodermal lacZ expression due to Abd-lacZ. The active form of MAPK, dp-MAPK (red) (Lai and Rubin, 1992; Rogge et al., 1995) , which serves as a repressor of btl expression. Biochemical evidence indicated the minimum btl enhancer region to contain binding sites for Aop.
Results

Requirement of bnl for late btl expression
btl RNA expression in tracheal cells is under the control of a network of regulatory elements which function at different stages of development (Ohshiro and Saigo, 1997) . Trh/ Tgo complexes specifically binding to three CMEs situated in a 200 bp-long minimal enhancer of btl are essential for early btl expression in tracheal placodes during stage 10-early stage 12 (Ohshiro and Saigo, 1997) . At stage 12, six major buds begin to grow out in different directions, each as a primary branch (Fig. 1N) . During stage 12, btl RNA expression in dorsal trunks (DT) and transverse connectives (TC) begins to decline and at late stage 13, btl RNA expression is restricted almost completely to growing branches such as dorsal branches (DB), visceral branches (VB), and anterior and posterior lateral trunks (LTa and LTp) (Fig. 1A , N, Ohshiro and Saigo, 1997) . Late btl expression may require genes other than trh and tgo in consideration of the extensively different expression patterns between Trh protein and btl RNA at stage 13/14 (compare Fig. 1A with Fig. 2B of Ward et al. (1998) ). Btl protein distribution at stage 13/14 appeared to reflect that of btl RNA (Fig. 1A, F) .
Bnl expression at stage 11 in the vicinity of growing ends of primary branches may be considered to serve as guide for primary branch outgrowth . By staining embryos for btl and bnl RNA, we found that, at stage 13-14, LTa/p, DB, and VB, all associated with late btl expression, were overlaid with ectodermal or mesodermal cells expressing bnl strongly (Fig. 1A-E, N) . bnl clusters at stage 13-14 apparently have no relevance to primary branch outgrowth. Since Bnl is a protein acting extracellularly, there should be a 1-2 h time lag between bnl mRNA production and the appearance of Bnl protein secretion, and hence, bnl expression pattern in stage 13/14 revealed by in situ hybridization may not reflect the real spatial and temporal expression pattern of Bnl protein. Since bnl mRNA was found to be continuously expressed near the presumptive ends of primary branches from stage 12 later on ( Fig. 1N ), presumptive primary branch end cells expressing btl at stage 13-14 may possibly receive Bnl signals produced in bnl-expressing cells 1-2 h before. Thus, we interpret the intimate spatial relationship between bnl and btl expression during stages 12-14 as suggesting that bnl is involved in regulation of late btl expression possibly required for terminal branch formation Guillemin et al., 1996) .
To determine whether Bnl activates btl expression, btl expression in embryos mutant for bnl and those misexpressing a bnl transgene was studied. In bnl mutant embryos, btl RNA expression remained almost completely normal up to the end of stage 11 (data not shown) but gradually diminished starting from stage 12 and, at stage 14, had virtually ceased to exist (Fig. 1G) . bnl was misexpressed in ectodermal cells using the UAS/Ga14 system (Brand and Perrimon, 1993) . As shown in Fig. 1H , strong btl RNA misexpression was observed when Ga14 was expressed in anterior ectodermal compartments using ptc-Gal4 as a driver. Similar enhanced btl expression also became apparent when UASbnl was driven by 69B-Gal4 (data not shown). bnl activity may thus be considered essential for late btl expression in the developing tracheal system.
btl is essential for its expression
Bnl is a ligand of Btl . Its requirement for btl expression may be an indication of the latter's depending on itself for expression. To verify this point, btl D Oh10 , a btl null mutant generated by imprecise P excision at the btl locus, was used (Ohshiro and Saigo, 1997) . This mutant possesses intact lacZ (a reporter gene) and btl enhancers but lacks the entire btl coding sequence (Ohshiro and Saigo, 1997) . At stage 13-14, significantly reduced lacZ mRNA signals were detected in embryos homozygous for btl D Oh10 irrespective of the presence or absence of UAS-bnl driven by ptc-Ga14 (Fig. 1I ). btl may thus be concluded to depend on itself for expression.
Involvement of Ras/MAPK pathway in Bnl/Btl signaling
The Ras/MAPK pathway is presumed to be involved in Bnl/Btl signaling (Reichman-Fried et al., 1994; Gabay et al., 1997) . Activation of MAP kinase (MAPK), encoded by rolled in the case of Drosophila, can be visualized by immunostaining with anti-di-phosphate MAPK antibody (a-dp; Gabay et al., 1997) . At stage 13-14, MAPK was found to be strongly activated in Btl-expressing LTa/p, VB, and DB cells near bnl clusters, but not to be activated in Btl-nonexpressing DT and TC ( Fig. 1K-M) . Activated MAPK signals appeared to accumulate mainly in nuclei as has been observed for cultured cells treated with mitogens (Lenormand et al., 1993) . Although there is a good correlation between di-phosphate MAPK expression and btl mRNA expression, most probably because of limited sensitivity of a-dp, only nuclei of btl-expressing Lta/p, VB, and DV cells situated near bnl clusters could be detected with this antibody (Fig. 1K) . MAPK activation at this stage appears dependent on Bnl since bnl transgene overexpression in stage 13-14 ectodermal cells caused robust MAPK activation in all tracheal cells 
Aop as negative regulator of btl transcription
Aop functions as a transcriptional repressor in many contexts of development (Lai and Rubin, 1992; Tei et al., 1992; Rogge et al., 1995; Gabay et al., 1996) . Aop appears to be inactivated through phosphorylation brought about by activated MAPK. Phosphorylated Aop is eliminated from nuclei and eventually degraded (O'Neill et al., 1994; Rebay and Rubin, 1995) . We thus sought to find whether aop is involved in Bnl/Btl-signaling-dependent btl expression.
Endogenous aop was first examined for possible importance in the regulation of btl expression using a strong hypomorphic aop mutant (aop 1 (Rebay and Rubin, 1995) , was misexpressed in developing trachea using the UAS/Gal4 system. As a Gal4 driver, btl-Gal4 was used (Shiga et al., 1996) . In UAS-aop ACT /btl-Gal4 embryos, little or no btl expression could be detected from stage 12 onwards (Fig. 2C ). Aop ACT is thus shown capable of repressing late btl expression.
In wild type, nuclear Aop signals are present in nearly all tracheal cells except for tip cells receiving the highest levels of Bnl ( Fig. 2D ; Lai and Rubin, 1992; Hacohen et al., 1998) , while, in aop 1 mutants, primarily in the cytoplasm (Fig. 2F ). Nuclear and probably cytoplasmic Aop signals were eliminated almost completely upon strong activation of Bnl/Btl signaling through bnl misexpression (Fig. 2E) . MAPK activated by Bnl/Btl signaling should thus stimulate the degradation of Aop and release Aop target genes from repression.
btl expression was considerably restored in bnl mutant embryos lacking aop activity ( D88 embryos, suggesting that pnt is essential for late btl expression. (I) btl RNA expression in a UAS-bnl/ptc-GAL4; pnt D88 embryo. btl induction was much lower than that in UAS-bnl/ptc-GAL4 embryos (compare to Fig. 1H ). Weak btl expression may be due to possible positive factors other than Pnt. Scale bar, 25 mm.
btl expression and inactivated in the presence of Bnl/Btl signaling in growing tracheal branches.
Pnt as a positive regulator of btl transcription
Pnt is another Ets domain containing protein and functions in the Ras/MAPK pathway downstream of receptortype tyrosine kinases. It is considered to be a transcriptional activator, in competition with Aop for targets (O'Neill et al., 1994; Brunner et al., 1994; Gabay et al., 1996) . Pnt is required for tracheal development, since tracheal defects similar to those of hypomorphic btl alleles were observed in pnt mutant embryos (Klambt, 1993) . To analyze Pnt involvement in late btl expression, btl expression was examined in pnt mutant embryos. In these embryos, btl expression gradually decreased and hardly remained by stage 14 (Fig. 2H) . The effect of bnl overexpression on btl induction was substantially reduced in a pnt mutant background (compare Fig. 2I with Fig. 1H ). Pnt thus could be acting downstream of or parallel to Bnl and Btl. But btl expression is not completely eliminated in UAS-bnl/ptc-Ga14 embryos homozygous for pnt (Fig.  2I) , and so some positive transcription factor other than Pnt would appear involved in tracheal btl expression. It might be presumed that this factor, acting downstream of Bnl/BtI signaling, is capable of serving as a substitute for Pnt under the condition of exceptionally high levels of Bnl/ Btl signaling activity whereas it activates btl expression in a manner synergistic with Pnt.
Binding of Aop to btl minimum enhancer
The minimum btl enhancer consists of B2 and B3 regions, the latter, a late enhancer (Ohshiro and Saigo, 1997) . lacZ expression driven by B3 enhancer mimics btl late expression (Fig. 3C ) and can be repressed by Aop ACT (Fig. 3D) . The B3 enhancer may thus contain binding sites for Aop. Ets-domain containing proteins binds to DNA via conserved Ets domains and the canonical sequence of their targets is 5 0 GGA (Nye et al., 1992) . The B3 enhancer contains an inverted repeat of GGA quite near 3 0 of CME2, a Trh/Tgo binding element (Ohshiro and Saigo, 1997; Fig. 3A) . Study was thus made to determine Aop-capability for binding to the GGA pair. The Ets domain of Aop (ETS AOP ) was expressed in Escherichia coli cells and partially purified from cell extracts followed by electrophoresis mobility shift assay (EMSA). Doublestranded oligonucleotides used as probes are shown in the lower margin of Fig. 3A . Fragment C contains only one GGA, while W is a portion of B3, containing the GGA pair. M1-M4 are mutants for GGA sites. As shown in lanes 1 and 2 in Fig. 3B and 6), strongly suggesting that targets for Aop in B3 are the GGA pair, ETS1 and ETS2.
To clarify whether ETS1 and ETS2 serve as Aop targets in vivo, enhancer activity of B3 fragment mutant for ETS1 and ETS2 was examined. As shown in Fig. 3E , LacZ expression driven by B3 with M2 mutation (B3[M2] ) was derepressed in TC, as also noted for that of btl on an aop mutant background (see Fig. 2A ). Weak derepression of btl expression was observed in DT. B3[M2]-driven lacZ expression was not repressed by misexpression of Aop ACT (compare Fig. 3F with Fig. 3D (Fig. 3F) . Note that the B3[M2] enhancer lacks both intact ETS1 and EST2.
Discussion
Regulation of late btl expression through positive feedback of Bnl/Btl signaling
Bnl/Btl signaling in developing trachea was previously shown not only to facilitate cell migration during primary branch formation but also to induce the expression of genes required for secondary and terminal branch formation in a subset of tracheal cells (Reichman-Fried and Shilo, 1995; Lee et al., 1996; Sutherland et al., 1996) . The present study indicates that the btl gene itself is a target of Bnl/Btl signaling and accordingly, Bnl/Btl signaling is regulated by a positive feedback mechanism (Fig. 4) . Our results also indicated that the positive feedback of Bnl/Btl signaling includes MAPK activation. To our knowledge, this is the first clear demonstration of the presence of a positive feedback loop in FGF signaling.
The positive feedback mechanism may be an important finding, since a negative feedback mechanism has already been shown to be involved in Bnl/Btl signaling (Hacohen et al., 1998) . Spry is expressed in many tissues including trachea and functions as an intracellular inhibitor of Ras pathway signal transduction through its binding to Drk and Gapl (Casci et al., 1999) . In embryos mutant for spry, downstream target genes of Bnl/Btl signaling are misexpressed and extra secondary branch cells are generated (Hacohen et al., 1998) . At the onset of secondary branch formation in wild type trachea, only one or a few cells exposed to the highest levels of Bnl overcome the inhibitory action of Spry to acquire secondary-branch-forming cell fate. Receptor molecules activated by ligands are generally considered eliminated from the cell membrane through endocytosis and the mechanism of Bnl/Btl-signaling-activity-dependent btl transcription should thus be indispensable to constant supply of fresh Btl receptors to membranes of cells receiving Bnl. A proper balance between positive effects from Btl supply and negative effects of Spry on Bnl/Btl signaling may accordingly be essential for properly selecting secondary budding cells in the vicinity of the FGF signaling center and inducing properly terminal branch formation.
In mammalian non-endothelial cells, the vascular endothelial growth factor (VEGF) is induced by hypoxia and VEGF, in turn, up-regulates its cognate receptor VEGFR-2 in nearby endothelial cells (Kremer et al., 1997) . Simultaneous activation of VEGF and cognate receptor may account for a mechanism of tumor angiogenesis in rat glioma (Plate et al., 1993) . Similarly, in Drosophila, oxygen deprivation during larval life stimulates the production of Bnl which then acts as a chemoattractant to guide new terminal branches to the expressing cells (Jarecki et al., 1999) . Although there is no direct evidence for Btl expression stimulation by oxygen deprivation, that btl is required for adult trachea formation (our unpublished data) and btl expression is positively regulated by bnl (present work) would strongly suggest that not only bnl but also btl expression is induced in response to oxygen deprivation and simultaneous induction of bnl and btl is responsible for extratrachea formation subsequent to oxygen deprivation.
Repression of late btl expression by Aop
aop is expressed in most developing tracheal cells and its protein product is localized mainly in the nucleus (Lai and Rubin, 1992) , except for tip cells which receive the highest levels of Bnl signals (Hacohen et al., 1998) . We showed that the misexpression of the activated form of Aop in tracheal cells virtually completely abolish Btl signals and that the absence of aop activity leads to btl misexpression in TC, from which btl expression is normally absent (see Fig. 2A) . Conversely, the overexpression of bnl, which stimulates Bnl/Btl signal transduction, brought about almost the complete elimination of Aop nuclear signals from most tracheal cells (see Fig. 2E ). The destabilization of Aop phosphorylated by the activated form of MAPK would be the most likely reason for this. It thus quite logically follows that the area of normal late btl expression is determined partly by an activity balance between ubiquitous Aop and Bnl/Btl signaling, whose activity should diminish gradually with distance from the Bnl source. Note that, in contrast to Spry, whose expression is under the control of Bnl/Btl signaling (Hacohen et al., 1998) , aop is transcribed constitutively in an Bnl/Btl-signaling-independent manner (Hacohen et al., 1998; our unpublished observation) . Fig. 2D shows that btl is expressed even in growing trachea branch cells associated with nuclear Aop signals. High concentration of Pnt may overcome Aop-dependent repression and activate btl in these cells. Pnt is thought to compete with Aop to activate target gene expression (Brunner et al., 1994; O'Neill et al., 1994; Gabay et al., 1996) . In pnt mutant embryos, btl expression is lost (Fig. 2H) , again indicating that Pnt activates btl expression. Pnt transcription has been shown to be dependent on Bnl/Btl signaling and, accordingly, Bnl/Btl signaling is expected to activate Pnt expression in Bnl receiving cells. Thus, that the threshold value of Bnl/Btl signaling for btl expression is much lower than that for elimination of nuclear Aop is likely due to the presence of this Pntmediated positive feedback regulation.
In wild type, little or no Btl expression occurs in DT and TC but btl misexpression was detected mainly in TC in aop mutants, so that btl expression may perhaps be repressed in DT by some factor other than Aop. We presume Spalt (Sal) to be responsible for btl repression in DT. sal encodes a Znfinger transcription factor and is expressed specifically in DT (Kuhnlein and Schuh, 1996) . sal is essential for DT fate determination (Kuhnlein and Schuh, l996) and its overexpression throughout the entire trachea almost completely abolished btl expression (our unpublished data). In sal mutants, btl expression was derepressed in presumptive DT cells which failed to migrate, with consequent accumulation at trachea center (our unpublished data).
In wild type embryo, DTa (anterior DT branch) and DTp (posterior DT branch) cease branch growth and start to fuse with adjacent metamers by stage14, whereas other primary branches continue to grow in a Bnl/Btl-signaling dependent manner . DTa and DTp extend no terminal branches, the formation of which requires Btl activity (Reichman-Fried and Shilo, 1995; Guillemin et al., 1996; Sutherland et al., 1996 , Hacohen et al., 1998 . The early down-regulation of btl RNA in DT may thus possibly be essential for preventing terminal branch formation in DT.
Direct binding of Aop to the btl minimum enhancer responsible for late expression
EMSA along with an enhancer assay (see Fig. 3 ) indicated that btl B3 enhancer, about 120 bp long and responsible for late btl expression contains an inverted repeat consisting of two Aop binding sites (GGAs; ETS1 and ETS2), suggesting that dimerized Aop binds to the B3 enhancer. Pnt is considered to compete with Aop for a common target sequence to activate target gene expression (Brunner et al., 1994; O'Neill et al., 1994; Gabay et al., 1996) . pnt is essential for late btl expression (see Fig. 2H ). Our unpublished data indicated that as with Aop, the Ets domain of Pnt (ETS PNT ) was capable of forming a complex not only with the authentic wild-type B3 enhancer, but with mutant forms of B3 enhancer as well. Pnt may thus be capable of binding to mutated ETSs or B3 sequences other than ETS1/ETS2 (see Fig. 3A ). As discussed above, btl expression in DT appears to be repressed by Sal. Sal is a close relative of Sal-related (Salr) and Sal and Salr share in common similar zinc-fingers, so that recognition of identical sequences as binding sites may be possible. Previous sequence analysis (Ohshiro and Saigo, 1997) indicated the B3 enhancer to contain a sequence similar to the Salr target in chorion s15 (Barrio et al., 1996) . This putative Sal/Salr binding site is situated in the B3 enhancer just in the 3 0 vicinity of ETS1; ETS2 and the putative Sal/Salr binding site may partly overlap. Our preliminary experiment showed that Sal is capable of binding to the B3 enhancer.
The B3 enhancer possesses two of three CMEs sites for binding of Trh/Tgo complexes (see Fig. 3A ; Ohshiro and Saigo, 1997) . The disruption of three CMEs in the btl enhancer was previously shown to bring about the complete loss of btl expression in tracheal cells at later stages (Ohshiro and Saigo, 1997) . Thus, Trh/Tgo may also be required for late btl expression. A POU-Homeobox containing protein, Ventral veinless (Vvl)/Drifter was previously reported required for maintenance of btl expression in developing trachea (Anderson et al., 1996) .
Pnt, Trh/Tgo, and Ventral veinless/Drifter thus quite likely synergistically activate btl expression in DB, VB, and LTa/p whereas Aop and/or Sal activity represses btl to prevent its expression in TC and/or DT.
Experimental procedures
Fly strains
The following fly strains were used: bnl P1 /TM3 , aop 1 (Nusslein-Volhard et al., 1984) , pnt D88 (Scholz et al., 1993) , UAS-aop ACT (Rebay and Rubin, 1995) , UAS-bnl , btl
and B3-lacZ transgenic fly (Ohshiro and Saigo, 1997) , btlGa14 (Shiga et al., 1996) , ptc-Gal4 (Wilder and Perrimon, 1995) . Mutant chromosomes are balanced with blue balancer chromosomes, CyO wg-lacZ or TM6B Abd-lacZ to distinguish homozygous or heterozygous embryos.
Immunohistochemistry
Two-color whole mount fluorescent in situ hybridization (FISH) was carried out using digoxygenin DIG-11-UTPlabeled btl-specific and biotin-16-UTP-labeled bnl-specific RNA probes. RNA probes were prepared using full-length btl cDNA or bnl cDNA as templates. Five micrograms of each probe was added in 1 ml of hybridization buffer (1 mg/ml tRNA, 20 mM Tris.Cl (pH 8.0), 2.5 mM EDTA, l £ Denhard's, 50% formamide, 30 mM NaCl, 5% Dextran sulfate). Hybridization was carried out for 16 h at 558C. After extensive wash, btl mRNA was detected by incubating samples with alkaline phosphatase conjugated anti-DIG antibody (1:1000 dilution) followed by developing using fluorescent substrates for alkaline phosphatase, HNPP/Fast Red TR (Boehringer Mannheim: Goto and Hayashi, 1997) . bnl mRNA signal was amplified by TSA-indirect system (NEN) and detected by incubation with FITC-labeled streptavidin (Pierce). Signals were detected using a laser scanning confocal microscope (MRC 1024, Bio-Rad). For non-fluorescent detection of bnl, btl, and lacZ mRNA, DIG-labeled RNA probes were used. The condition of hybridization was the same as above. Signals were detected by incubating samples with alkaline phosphatase conjugated anti-DIG antibody (1:1000 dilution) followed by developing using BCIP/NBT (Boehringer Mannheim) as an alkaline phosphatase substrate. Signals were developed by incubating samples for 1 h at 258C. Mouse monoclonal anti-Aop antibody (used at 1:20 dilution) was a gift of I. Rebay and G. Rubin. Anti-diphosphate MAPK antibody (used at 1:20 dilution; Gabay et al., 1997) was purchased from Sigma. Rabbit polyclonal anti-lacZ protein (b galactosidase; Pierce) was used at 1:2000 dilution for embryos shown in Fig. 3C , D. Mouse monoclonal anti-b galactosidase (Promega) was used at 1:500 dilution for embryos shown in Fig. 3E , F. Rabbit polyclonal anti-Btl antibody was raised against the cytoplasmic domain of Btl. Affinity purified anti-Btl antibody was used at 1:300 dilution. Biotin-conjugated goat anti-rabbit or anti-mouse antibodies were used at 1:5000 dilution. Signals were detected using ABC kit (Vector).
EMSA
Polymerase chain reaction (PCR) fragments encoding the Ets domain of Aop (amino acid position: 388-493; Lai and Rubin, 1992) was cloned into pRSETC vector (Invitrogen). Hexahistidine-tagged Ets domain of Aop (ETS AOP ) was overexpressed in E. coli BL21 (DE3) pLysS cells and partially purified using His Bind Resin (Novagen). Annealed complementary oligonucleotides were endlabeled with [g 32 P]ATP and T4 polynucleotide kinase (TOYOBO,.Co., Ltd). W corresponds to a part of B3 enhancer (2510 to 2484 bp upstream of btl P2 transcription start site; Ohshiro and Saigo, 1997) , containing CME2 and two putative Ets-binding sites. M1-M4 are derivatives of W (see Fig. 3A ). Fragment C is an annealing product of 5 0 -GGTCGAGACTTCCGGTTGTCGA and 5 0 -GTCGA-CAACCGGAAGTCTCGAC. Fragment C contains a single Ets-domain-binding consensus sequence (SC1; Nye et al., 1992) . A typical reaction mixture (11 ml) contained 200 ng of ETS AOP , 7% glycerol, 25 mM K 1 HEPES at pH 7.5, 50 mM KCl, 0.1 mM EDTA and 0.1% NP-40. As a nonspecific competitor, we used a short double-stranded oligonucleotide, CME1 mut5 (Ohshiro and Saigo, 1997) , which lacks putative binding sites for Ets-domain polypeptides. Neither Herring sperm DNA nor poly I-dC was used as non-specific competitors, since they served as efficient Ets-domain targets. The mixture was kept at 48C for 1 h prior to the addition of labeled probe (10 4 cpm). Reaction was carried out by a 30 min incubation at room temperature, and reactants were analysed using 4% polyacrylamide gel electrophoresis in 0.5 £ TBE.
In vitro mutagenesis and plasmid construction
Ets site mutant plasmid (B3[M2]-driven lacZ) was generated using the Kunkel method. Transgenic flies with a B3[M2]-driven lacZ transgene were generated by P element mediated germ-line transformation.
